Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiology
New angiology study findings have been reported by researchers in Japan and the United States
February 14th, 2007
Studies from Japan and the United States further understanding of angiology. Study 1: Researchers detail in "Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus," new data in angiology. According to recent research from Yokohama, Japan, "PGE, a potent vasodilator, plays a primary role in maintaining the patency of the ductus arteriosus (DA). Genetic disruption of the PGE-specific receptor EP4, however, paradoxically results in fatal patent DA (PDA) in mice." "Here we demonstrate that EP4-mediated signals promote DA closure by hyaluronic acid-mediated (HA-mediated) intimal...
Source: Medical Patent Law Weekly (2007-02-14)
|
